Researcher.Life Logo

EMBO Molecular Medicine : Impact Factor & More

eISSN: 1757-4684pISSN: 1757-4676
JournalOpen Access

Key Metrics

CiteScore
16.2
Eigenfactor
0.01 - 0.05
H-Index
130
Impact Factor
10 - 15
Scite Index
0.95 5-Year SI
SJR
Q1Molecular Medicine
SNIP
2.15
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on EMBO Molecular Medicine

EMBO Molecular Medicine Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
Article Processing ChargesUSD 5000 | GBP 3960 | EUR 4500
Publication Time26
Editorial Review ProcessAnonymous peer review,Double anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorEMBO
FrequencyMonthly
Publication Start Year2009
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 26
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review,Double anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in EMBO Molecular Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in EMBO Molecular Medicine

Disease-stage-specific immunometabolic remodeling in pediatric obstructive sleep apnea: a single-cell transcriptomic atlas of adenoid tissue
  • 27 Apr 2026
  • EMBO Molecular Medicine
Systemic delivery of AAV-GFM1 corrects COXPD1 molecular alterations in Gfm1R671C/- mice.
  • 17 Apr 2026
  • EMBO molecular medicine
Pharmacological targeting of the NLRP3 LRR domain with isothiazolinones overcomes CRID3-resistant inflammation.
  • 17 Apr 2026
  • EMBO molecular medicine
Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity.
  • 17 Apr 2026
  • EMBO molecular medicine
Organelle resilience as a comparative blueprint for longevity.
  • 16 Apr 2026
  • EMBO molecular medicine
Hypothalamic regulation of sepsis-associated anorexia: cytokine and hormonal signalling through AgRP/POMC circuits.
  • 15 Apr 2026
  • EMBO molecular medicine
Disease-stage-specific immunometabolic remodeling in pediatric obstructive sleep apnea: a single-cell transcriptomic atlas of adenoid tissue
  • 27 Apr 2026
  • EMBO Molecular Medicine
Systemic delivery of AAV-GFM1 corrects COXPD1 molecular alterations in Gfm1R671C/- mice.
  • 17 Apr 2026
  • EMBO molecular medicine
Pharmacological targeting of the NLRP3 LRR domain with isothiazolinones overcomes CRID3-resistant inflammation.
  • 17 Apr 2026
  • EMBO molecular medicine
Neoantigens and shared MICB α3 antigen dual-targeted vaccine generates potent antitumor immunity.
  • 17 Apr 2026
  • EMBO molecular medicine
Organelle resilience as a comparative blueprint for longevity.
  • 16 Apr 2026
  • EMBO molecular medicine
Hypothalamic regulation of sepsis-associated anorexia: cytokine and hormonal signalling through AgRP/POMC circuits.
  • 15 Apr 2026
  • EMBO molecular medicine

FAQs on EMBO Molecular Medicine